ANDA 75901, held by Actavis Elizabeth. Fluvoxamine Maleate.
As of Nov 16, 2026, ANDA 75901 (Fluvoxamine Maleate), held by Actavis Elizabeth, was first approved by FDA on Dec 28, 2000, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 28, 2000 | Original application | Approved |
| Fluvoxamine Maleate25MG · tablet;oral | Fluvoxamine Maleate | Discontinued |
| Fluvoxamine Maleate50MG · tablet;oral | Fluvoxamine Maleate | Discontinued |
| Fluvoxamine Maleate100MG · tablet;oral | Fluvoxamine Maleate | Discontinued |
| Jul 24, 2002 | Supplement 2Labeling | Approved | None posted |
| Nov 2, 2001 | Supplement 1Manufacturing | Approved | None posted |
| Dec 28, 2000 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters